Summary
Striatal dopamine (DA) is critical for action and learning. Recent data show DA release is under tonic inhibition by striatal GABA. Ambient striatal GABA tone on striatal projection neurons can be governed by plasma membrane GABA uptake transporters (GATs) on astrocytes. However, whether striatal GATs and astrocytes determine DA output are unknown. We reveal that DA release in mouse dorsolateral striatum, but not nucleus accumbens core, is governed by GAT-3 and GAT-1. These GATs are partly localized to astrocytes, and are enriched in dorsolateral striatum compared to accumbens core. In a mouse model of parkinsonism, GATs become downregulated and tonic GABAergic inhibition of DA release augmented, despite attenuated GABA co-release from dopaminergic axons. These data define previously unappreciated and important roles for GATs and astrocytes in determining DA release in striatum, and reveal that they underlie maladaptive plasticity in early parkinsonism that impairs DA output in vulnerable striatal regions.
GABA transporters set the level of GABA inhibition of DA output in dorsal striatum
Astrocytes facilitate DA release by limiting tonic GABA inhibition
Tonic GABA inhibition of DA release is augmented in mouse model of parkinsonism
DA and GABA co-release are reduced in mouse model of parkinsonism